Reply: clinical experience with prophylactic fondaparinux in critically ill patients with moderate to severe renal impairment or renal failure requiring renal replacement therapy

Ann Pharmacother. 2015 May;49(5):614-5. doi: 10.1177/1060028015571658.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticoagulants / therapeutic use*
  • Critical Illness / therapy*
  • Female
  • Humans
  • Male
  • Polysaccharides / therapeutic use*
  • Renal Insufficiency / drug therapy*
  • Renal Insufficiency / surgery*
  • Renal Replacement Therapy*

Substances

  • Anticoagulants
  • Polysaccharides